23 February 2022 Meeting date 23 February 2022 Recommendations on vaccination of children 5 - 11 years with mRNA vaccine from the Pfizer laboratory Maintain homologous schedules using the vaccines authorized for the different age groups (Sinopharm 3 and 4 years, Pfizer 5 to 11 years). Administer an additional dose in cases of immunocompromised hosts using the same vaccine as the one used previously. Wait for further evidence before recommending a booster dose in the 3 to 11 years age group. Work on the availability of vaccines at the jurisdictional level. Increase efforts to reach the unvaccinated population. Co-administration with other vaccines is recommended. Implement strategies for the recovery of coverage for routine vaccines schedule vaccines. Full text: https://www.argentina.gob.ar/sites/default/files/2022/01/acta_conain_23_de_febrero_2022.pdf Country Argentina Keywords